Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Nat Genet. 2012 Aug 26;44(10):1122–1125. doi: 10.1038/ng.2388

Figure 2.

Figure 2

Glioma case-control odds ratios (ORs), 95% confidence intervals (CIs), and (−log10p) for SNPs within the 8q24.21 (CCDC26) region. A: Associations of all gliomas with 7 most strongly and significantly associated SNPs along with two SNPs from prior studies (1, 2) (rs4295627 and rs891835). B: Associations of rs55705857 G allele with various glioma morphologic subtypes. C: Association of rs55705857 G allele with glioma morphologic subtypes further stratified by presence or absence of tumor IDH1 or IDH2 mutation. Only Stage 2 validation genotyping data are illustrated. Abbreviations: MOA=mixed oligoastrocytoma, Oligo=oligodendroglioma, GBM=glioblastoma